Cart
0
0.00 €

PROGRAM

Order your tickets here. 

                                                 Morning

09.00h – 09.35h 'ATMP Belgium, landscape overview' - Nathalie Cools, anicells

09.35h – 09.45h 'at.las and the ATMP Logistics Excellence Centre' - Jade Verrept, at.las

09.45h – 10.30h Panel discussion 'Cross supply chain collaboration – can ATMP lead by example?'

  • Melissa Van Pel, NecstGen & Bastian Friedrich, Arvato & Loïc Struyf, N-Side - moderated by Erik Agterhuis, Life Cell Science

11.00h – 12.00h Panel discussion 'The human factor – how to derisk logistical operations?'

  • Charlotte Meuldermans, Deloitte & Agnieszka Cooijmans, Cryoport & Davy De Block, 4 Advice & Frank Van Gelder, Mediconed - moderated by Jade Verrept, at.las

Afternoon

Focus 'ATMP supply chain models - case studies': 

  • 13.30h – 13.55h: ''Supplying ATMP's through Decentralized Manufacturing'' - Tim Aerts, Galapagos

  • 14.00h – 14.25h: 'The challenges of setting up a resilient centralized supply chain' - Jessica Torfs, J&J

  • 14.25h – 14.45h : Q&A 

  • 15.00h – 15.25h: 'Why it matters to provide a personalized service to ATMP shippers." - Peter Allard, Deliver-IT   

  • 15.30h – 15.55h: 'The need to standardize - how to improve ATMP supply chain solutions.' - Frank Van Gelder, Pharma.aero

  • 15.55h – 16.30h: Q&A

OR 

Focus 'Manufacturing - the integration of closed and automated platforms in the production of ATMP - case studies' : 

  • 13.30h – 14.00h: 'The objective of anicells 2.0 and how it helps cell therapy developers in the valorisation of their product.' - Nathalie Cools, anicells

  • 14.00h – 14.45h: Case Study Miltenyi Biotec - Sander Van de Weg, Miltenyi & Sergio Navarro Velàzquez, Hospital Clinic de Barcelona

  • 14.45h – 15.30h: Case Study Scinus Cell Expansion - Ruud Das, Scinus Cell Expansion & Liesbet Geris, KU Leuven

  • 15.30h – 16.00h: 'Advantages of manufacturing in an automated, closed system, experiences from the Galapagos trial.' - Jeroen Buskermolen, Galapagos

  • 16.00 – 16.30h: 'The factory-of-the-future for ATMP, a far dream or close to reality?' - Jan Schrooten, Antleron


Plenary Closing Session

  • 16.30h –  17.00h : 'The patient perspective - the promise of ATMP.' - dr. Toon Van Genechten, UZA
  • 17.00h –  17.15h : closing remarks.   

Networking

  • Connect and Network : during the day you will have ample opportunity to connect and network with other participants.
  • Innovative solutions : in designated area, you can visit the booths of our sponsors and partners and discover their solutions.